Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites

The overexpression of soluble human leukocyte antigen-G is associated with malignant tumours. The purpose of our study was to detect soluble human leukocyte antigen-G concentrations in ascites and to evaluate the value of ascitic soluble human leukocyte antigen-G for the diagnosis of malignant ascit...

Full description

Bibliographic Details
Main Authors: Juan Sun, Yan-Xiang Chang, Chun-Yan Niu
Format: Article
Language:English
Published: IOS Press 2017-11-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317726840
id doaj-9d31df12c04d4c4ba5a780a8717fb7a5
record_format Article
spelling doaj-9d31df12c04d4c4ba5a780a8717fb7a52021-05-02T18:36:48ZengIOS PressTumor Biology1423-03802017-11-013910.1177/1010428317726840Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascitesJuan Sun0Yan-Xiang Chang1Chun-Yan Niu2Xi’an Medical University, Xi’an, ChinaDepartment of Oncology, The First Affiliated Hospital of Xi’an Medical University, Xi’an, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, Xi’an, ChinaThe overexpression of soluble human leukocyte antigen-G is associated with malignant tumours. The purpose of our study was to detect soluble human leukocyte antigen-G concentrations in ascites and to evaluate the value of ascitic soluble human leukocyte antigen-G for the diagnosis of malignant ascites. Enzyme-linked immunosorbent assay was used to detect soluble human leukocyte antigen-G levels in 64 patients with malignant ascites and 30 patients with benign ascites. Receiver operating characteristic curves were used to evaluate the diagnostic efficacy of ascitic soluble human leukocyte antigen-G for the detection of malignant ascites. Ascitic soluble human leukocyte antigen-G levels were significantly higher in the malignant ascites group than in the benign ascites group (20.718 ± 3.215 versus 12.467 ± 3.678 µg/L, t = 7.425, p  < 0.001). The area under the receiver operating characteristic curve for ascitic soluble human leukocyte antigen-G was 0.957 (95% confidence interval, 0.872–0.992). At a cut-off value of 19.60 µg/L, the sensitivity and specificity of ascitic soluble human leukocyte antigen-G were 87.5% (95% confidence interval, 71.0%–96.5%) and 100% (95% confidence interval, 88.4%–100%), respectively. With respect to area under the receiver operating characteristic curve, sensitivity and specificity, ascitic carcinoembryonic antigen (0.810, 68.75% and 83.33%, respectively) and carbohydrate antigen 19-9 (0.710, 65.63% and 70%, respectively) significantly differed (all p  < 0.05). In malignant ascites that were cytology-negative and biopsy-positive, the rate of positivity for ascitic soluble human leukocyte antigen-G was 75%, which was higher than the corresponding rates for ascitic carcinoembryonic antigen (31.25%) and carbohydrate antigen 19-9 (6.25%; both p  < 0.05). In conclusion, The detection of ascitic soluble human leukocyte antigen-G exhibited good performance for diagnosing malignant ascites, and particularly those that were cytology-negative and biopsy-positive.https://doi.org/10.1177/1010428317726840
collection DOAJ
language English
format Article
sources DOAJ
author Juan Sun
Yan-Xiang Chang
Chun-Yan Niu
spellingShingle Juan Sun
Yan-Xiang Chang
Chun-Yan Niu
Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
Tumor Biology
author_facet Juan Sun
Yan-Xiang Chang
Chun-Yan Niu
author_sort Juan Sun
title Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
title_short Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
title_full Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
title_fullStr Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
title_full_unstemmed Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
title_sort evaluation of ascitic soluble human leukocyte antigen-g for distinguishing malignant ascites from benign ascites
publisher IOS Press
series Tumor Biology
issn 1423-0380
publishDate 2017-11-01
description The overexpression of soluble human leukocyte antigen-G is associated with malignant tumours. The purpose of our study was to detect soluble human leukocyte antigen-G concentrations in ascites and to evaluate the value of ascitic soluble human leukocyte antigen-G for the diagnosis of malignant ascites. Enzyme-linked immunosorbent assay was used to detect soluble human leukocyte antigen-G levels in 64 patients with malignant ascites and 30 patients with benign ascites. Receiver operating characteristic curves were used to evaluate the diagnostic efficacy of ascitic soluble human leukocyte antigen-G for the detection of malignant ascites. Ascitic soluble human leukocyte antigen-G levels were significantly higher in the malignant ascites group than in the benign ascites group (20.718 ± 3.215 versus 12.467 ± 3.678 µg/L, t = 7.425, p  < 0.001). The area under the receiver operating characteristic curve for ascitic soluble human leukocyte antigen-G was 0.957 (95% confidence interval, 0.872–0.992). At a cut-off value of 19.60 µg/L, the sensitivity and specificity of ascitic soluble human leukocyte antigen-G were 87.5% (95% confidence interval, 71.0%–96.5%) and 100% (95% confidence interval, 88.4%–100%), respectively. With respect to area under the receiver operating characteristic curve, sensitivity and specificity, ascitic carcinoembryonic antigen (0.810, 68.75% and 83.33%, respectively) and carbohydrate antigen 19-9 (0.710, 65.63% and 70%, respectively) significantly differed (all p  < 0.05). In malignant ascites that were cytology-negative and biopsy-positive, the rate of positivity for ascitic soluble human leukocyte antigen-G was 75%, which was higher than the corresponding rates for ascitic carcinoembryonic antigen (31.25%) and carbohydrate antigen 19-9 (6.25%; both p  < 0.05). In conclusion, The detection of ascitic soluble human leukocyte antigen-G exhibited good performance for diagnosing malignant ascites, and particularly those that were cytology-negative and biopsy-positive.
url https://doi.org/10.1177/1010428317726840
work_keys_str_mv AT juansun evaluationofasciticsolublehumanleukocyteantigengfordistinguishingmalignantascitesfrombenignascites
AT yanxiangchang evaluationofasciticsolublehumanleukocyteantigengfordistinguishingmalignantascitesfrombenignascites
AT chunyanniu evaluationofasciticsolublehumanleukocyteantigengfordistinguishingmalignantascitesfrombenignascites
_version_ 1721488786486984704